Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Forward-looking statements may include, among others, statements concerning future financial or operating performance, including our ability to (i) further evolve our pharmacy benefit management model, (ii) increase access to medicines, (iii) drive greater simplicity with strategies to further reduce cost and improve health and pharmacy care, (iv) drive transparency and predictability to consumers and clients, (v) enhance disclosure practices
The BUD represents the last day your pharmacy guarantees potency and safety
Based on the pricing of Tirzepatide (Zepbound at approximately $1,060 per month) and Semaglutide (Wegovy at approximately $1,350 per month), analysts project Retatrutide could cost between $1,200 and $1,500 per month at retail once approved
Nei giorni di riposo 3-5 g assieme a un pasto insulinostimolante composto da carboidrati, proteine o carboidrati e proteine
US$ 21.36
US$ 28.07
US$ 22.75
US$ 23.64
US$ 26.85
